Choroidal Changes Post Short Term Exposure To Virtual Reality Devices

Visu, Inc.

Overview

This is a prospective, randomized, controlled, contralateral eye, clinical study. The objective of the study is to determine the impact of Virtual Reality (VR) usage on choroidal thickness when viewed through a test display compared to a control (standard) VR display. The hypothesis is that there will be less choroidal thinning in the eye viewing the test VR screen compared to the eye viewing the control VR screen.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

TRIPLE

Conditions

Myopia

Interventions

VisuDEVICE

An experimental (test) virtual reality display

Eligibility

Sex: ALLMin age: 13 YearsHealthy volunteers:

Medical Language ↔ Plain English

Key Inclusion Criteria: * Is at least 13 years of age and has full legal capacity to volunteer; * Has read and signed an information consent letter; * Visual Acuity of +0.20 logMAR or better in each eye; * Is willing and able to follow instructions and maintain the appointment schedule. Key Exclusion Criteria: * Is participating in any concurrent clinical or research study; * Has any known active ocular disease and/or infection; * Has a systemic condition that in the opinion of the investigator may affect a study outcome variable; * Is amblyopic in either eye; * Has a colour vision abnormality; * Commonly experiences motion sickness.

Outcomes

Primary Outcomes

Choroidal thickness

Time frame: 2 hours

Secondary Outcomes

Choroidal thickness

Time frame: 3 months

Axial length

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.